Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Depreciation and Depletion (2016 - 2020)

Champions Oncology (CSBR) has 11 years of Depreciation and Depletion data on record, last reported at $254000.0 in Q4 2020.

  • For Q4 2020, Depreciation and Depletion rose 56.79% year-over-year to $254000.0; the TTM value through Oct 2020 reached $295000.0, up 49.75%, while the annual FY2025 figure was $150000.0, 2.74% up from the prior year.
  • Depreciation and Depletion reached $254000.0 in Q4 2020 per CSBR's latest filing, up from $224000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $254000.0 in Q4 2020 and bottomed at -$367000.0 in Q2 2020.
  • Average Depreciation and Depletion over 5 years is $63176.5, with a median of $98000.0 recorded in 2018.
  • Peak YoY movement for Depreciation and Depletion: surged 208.33% in 2018, then tumbled 54.85% in 2020.
  • A 5-year view of Depreciation and Depletion shows it stood at $35000.0 in 2016, then skyrocketed by 137.14% to $83000.0 in 2017, then soared by 38.55% to $115000.0 in 2018, then surged by 40.87% to $162000.0 in 2019, then soared by 56.79% to $254000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $254000.0 in Q4 2020, $224000.0 in Q3 2020, and -$367000.0 in Q2 2020.